Purchase Order 75N95021P00289

This is a $27,992,718.00 definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Inflammatix, Inc., a self-certified small disadvantaged business, for the development of a full stack of host-response solutions to address infectious disease testing for acute infections and sepsis. The contract is for the period of September 25, 2019 through May 7, 2027 and is a cost-sharing arrangement. No set-aside was used for this award....

This is a $19,543,164.01 definitive, firm-fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Rush University Medical Center. The contract is for a study titled "Innovative Support for Patients with SARS-CoV-2 Infections (INSPIRE) Registry" to determine the outcomes of SARS-CoV-2 infections among different age groups in the U.S. population. The contract was originally awarded on September 1, 2020 for an 18-month study with 4,800 participants. The CDC...

This federal contract award, valued at $749,549.00, was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Immunexpress Inc., a for-profit foreign-owned company. The contract is for the "ASSESSMENT & TRIAGE OF PATIENTS WITH ESCALATING SIGNS OF COVID-19 DISEASE USING A HOST RESPONSE TEST FOR SEPSIS" and is a definitive, firm-fixed-price contract with a period of performance ending on June 10, 2023. The contract award originated from a Broad...

This cost-plus-fixed-fee contract was awarded by the Centers for Disease Control and Prevention to Vitalant Research Institute to characterize the seroprevalence of SARS-CoV-2 antibodies in the U.S. population through May 2024. The $46.4 million contract expands Vitalant's ongoing work under the National SARS-CoV-2 Seroincidence Studies in Blood Donors contract to provide additional longitudinal data on antibody stability and reinfection risk through testing approximately 130,000 blood donors....

This is a $1,842,580.00 firm-fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Premier Healthcare Solutions, Inc., a for-profit healthcare data and analytics company based in Charlotte, North Carolina. The contract is for the provision of comprehensive and longitudinal inpatient and hospital-based outpatient healthcare data to support the CDC's COVID-19 response, post-COVID activities, and other public health priorities. The contract has a base period of...

The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a $120,000.00 firm fixed price purchase order contract to Olink Proteomics AB, a foreign-owned for-profit company, to provide an "Inflammation Analysis Service" from September 15, 2021 to June 15, 2022. The contract was awarded without any set-aside designation. The original solicitation indicates this was a sole-source award to Olink Proteomics AB, as...

The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $596,050 firm fixed price purchase order to Cytek Biosciences, Inc. to provide a Cytek Flow Cytometry Analysis System in support of COVID-19 response efforts. The system will be delivered to and utilized at Cytek's facility in Fremont, California over a period of approximately ten days in April 2021. No subcontractors or set aside designations were...

This contract was awarded by the Defense Advanced Research Projects Agency (DARPA) to Inflammatix, Inc., a small disadvantaged business, for the development of a host-response prognostic tool called HOSTDXTM-COVID SEVERITY. The $453,851.00 contract is for research, development, and testing services related to diagnostic solutions for COVID-19 and other viral pandemics. Inflammatix has received over $29 million in federal contracts and grants from the Department of Health and Human Services to...

The Department of Health and Human Services Food and Drug Administration awarded a $87,620 purchase order to Olink Proteomics Inc. of Waltham, Massachusetts. The firm fixed price contract is for quantitative proteomics measurement of 100 human COVID-19 plasma samples. Performance will take place in Waltham from July 18, 2023 through December 8, 2023. The solicitation sought quantitative proteomics measurement of the specified plasma samples, as described in the attached combined synopsis and...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $246,214 firm fixed price purchase order to Olink Proteomics Inc. to deliver Olink reagent kits and protein expression instrumentation. Specifically, the contract calls for 30 units of the Olink Target 96 Inflammation Kit, 20 units of the Olink Target 96 Immune Response Kit, and 51 units of the Olink 96.96 IFC for Protein Expression to be delivered to the...